PDL BioPharma Company Profile (NASDAQ:PDLI)

Analyst Ratings

Consensus Ratings for PDL BioPharma (NASDAQ:PDLI) (?)
Ratings Breakdown: 2 Hold Rating(s)
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $4.00 (13.31% upside)

Analysts' Ratings History for PDL BioPharma (NASDAQ:PDLI)
Show:
DateFirmActionRatingPrice TargetActions
4/17/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/23/2016Royal Bank Of CanadaLower Price TargetSector Perform$5.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/27/2014 forward)

Earnings

Earnings History for PDL BioPharma (NASDAQ:PDLI)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/3/2016        
5/4/2016Q116$0.50$0.52$142.05 million$103.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2016Q415$0.54$0.61$149.20 million$178.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/4/2015Q315$0.61$0.42$164.80 million$124.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2015Q215$0.52$0.47$137.75 million$138.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.52$0.50$140.80 million$149.71 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2015Q414$0.57$0.32$158.15 million$117.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314$0.56$0.61$165.10 million$164.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/18/2014Q214$0.46$0.52$134.07 million$162.80 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114$0.45$0.44$130.93 million$139.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/3/2014Q413$0.43$0.39$115.22 million$110.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2013Q313$0.37$0.36$97.09 million$97.30 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2013Q2 2013$0.54$0.62$138.20 million$143.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/9/2013Q1 2013$0.35$0.36$91.69 million$91.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/1/2013Q4 2012$0.31$0.34$86.08 million$86.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312$0.33$0.32$85.03 million$85.20 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.44$0.52ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012$0.27$0.29ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/23/2012$0.28$0.24ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2011$0.27$0.28ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011$0.39$0.39ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2011$0.24$0.25ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/28/2011$0.21$0.20ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PDL BioPharma (NASDAQ:PDLI)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Current Dividend Information for PDL BioPharma (NASDAQ:PDLI)
Annual Dividend:$0.20
Dividend Yield:5.67%
Payout Ratio:10.87% (Based on Trailing 12 Months of Earnings)
37.04% (Based on Current Year Consensus EPS Estimate)
400.00% (Based on Next Year Consensus EPS Estimate)

Dividend History for PDL BioPharma (NASDAQ:PDLI)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/4/2016quarterly$0.056.25%6/2/20166/6/20166/13/2016Tweet This Announcement  Share This Announcement on StockTwits
2/1/2016quarterly$0.057.27%3/2/20163/4/20163/11/2016Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015quarterly$0.158.22%9/2/20169/4/20169/11/2016Tweet This Announcement  Share This Announcement on StockTwits
2/2/2015quarterly$0.158.22%6/1/20166/5/20166/12/2016Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%6/3/20156/5/20156/12/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%3/3/20153/5/20153/12/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%12/2/201512/4/201512/11/2015Tweet This Announcement  Share This Announcement on StockTwits
1/30/2015quarterly$0.158.23%9/2/20159/4/20159/11/2015Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%9/3/20149/5/20149/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%3/3/20143/5/20143/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%12/3/201412/5/201412/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014quarterly$0.156.59%6/3/20146/5/20146/12/2014Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%12/3/201312/5/201312/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%6/3/20136/5/20136/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013quarterly$0.158.72%9/3/20139/5/20139/12/2013Tweet This Announcement  Share This Announcement on StockTwits
1/30/2013quarterly$0.158.72%3/1/20133/5/20133/12/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for PDL BioPharma (NASDAQ:PDLI)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
12/15/2015Peter S. GarciaCFOBuy5,000$3.64$18,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/14/2015Peter S. GarciaCFOBuy10,000$3.42$34,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/7/2015Steffen PietzkeCAOBuy20,590$3.64$74,947.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Peter S GarciaCFOBuy20,000$5.83$116,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Harold E SelickDirectorBuy6,000$8.08$48,480.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for PDL BioPharma (NASDAQ:PDLI)
DateHeadline
07/22/16 05:38 PMCash And Short-Term Investments For PDL BioPharma, Inc. (NASDAQ:PDLI) Was $220.352 - Stocks Daily
07/22/16 05:38 PMNotable Buzzers: Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
07/21/16 08:39 AMBroker Outlook For PDL BioPharma, Inc. (NASDAQ:PDLI) - Fiscal Standard
07/19/16 05:53 PMAnalysts Actions to Track: Gilead Sciences, Inc. (NASDAQ:GILD) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
07/19/16 05:53 PMNews review of 2 biotech stocks: PDL BioPharma, Inc. (NASDAQ:PDLI), Regeneron Pharmaceuticals, Inc. (NASDAQ ... - The Voice Registrar
07/19/16 06:10 AMShares Lower on the Year PDL BioPharma, Inc. (NASDAQ:PDLI) - Press Telegraph
07/19/16 06:10 AMIs $4 Price Target Attainable For PDL BioPharma, Inc. (NASDAQ:PDLI)? - Investor Newswire
07/18/16 03:09 PMPDL BioPharma, Inc. – Value Analysis (NASDAQ:PDLI) : July 18, 2016 -
07/16/16 09:00 AM3 Stocks in Focus: Corporate Office Properties Trust (OFC), PDL BioPharma, Inc. (PDLI), Cosi Inc. (COSI) - iStreetWire
07/15/16 10:51 AMPDL BioPharma Inc Realized Volatility Hits Elevated Level - CML News
07/13/16 06:06 PMHow Many PDL BioPharma Inc (NASDAQ:PDLI)'s Analysts Are Bullish? - Consumer Eagle
07/13/16 08:43 AMNoticeable Analyst's ideas: UnitedHealth Group Incorporated (NYSE:UNH) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
07/12/16 06:00 PMOption Market: PDL BioPharma Inc Risk Hits An Inflection Point - CML News
07/11/16 05:44 PMStrong Sell Calls For PDL BioPharma, Inc. (NASDAQ:PDLI) At 0 - Investor Newswire
07/11/16 07:25 AMPDL BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : PDLI-US : July 11, 2016 -
07/08/16 08:41 AMPDL BioPharma, Inc. Stock Momentum Hits Weakness - CML News
07/08/16 08:41 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Boasts $220.352 In Cash And Equivalents - Stocks Daily
07/07/16 08:39 AMAre Analysts Bullish PDL BioPharma Inc (NASDAQ:PDLI) After Last Week? - Engelwood Daily
07/06/16 10:25 AMShares now down at $3.09 PDL BioPharma Closes Equity Investment…
07/06/16 08:06 AMPDL BIOPHARMA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Completion of Acquisition or Disp -
07/06/16 06:11 AMPDL BioPharma Closes Equity Investment Transaction in Noden Pharma for the Acquisition of Tekturna® (aliskiren) and Tekturna HCT® (aliskiren and hydrochlorothiazide) - [at noodls] - INCLINE VILLAGE, Nev., July 6, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI) today announced that PDL has completed an initial equity investment of $75 million in Noden Pharma DAC (Noden), ...
07/04/16 04:59 PMAccounts Payable For PDL BioPharma, Inc. (NASDAQ:PDLI) Reach $0.662 - RealistInvestor.com
07/04/16 10:26 AMShare Performance Recap for: PDL BioPharma, Inc. (NASDAQ:PDLI) - Press Telegraph
07/03/16 05:07 PMPDL Biopharma Inc (NASDAQ:PDLI) Institutional Investor Sentiment Is 1.06 - Press Telegraph
07/01/16 08:32 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Cash And Short-Term Investments In Stands At $220.352 - Stocks Daily
06/27/16 05:47 PMBroker Outlook For The Week Ahead PDL BioPharma, Inc. (NASDAQ:PDLI) - Fiscal Standard
06/27/16 05:47 PMStrong Sell Calls Recommendations For PDL BioPharma, Inc. (NASDAQ:PDLI) At 0 - Investor Newswire
06/24/16 08:22 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Quarterly Dividend Payout At $-8.233 Millions - Stocks Daily
06/21/16 10:09 AMPDL BioPharma Inc(NASDAQ:PDLI) Declares Dividend of $0.0500. - TheFounders Daily
06/20/16 02:41 PMPDL BioPharma, Inc. Is Off 10% in 2016, and This Is a Big Reason Why - The "Queen" has fallen, and so has PDL BioPharma's dividend.
06/20/16 07:21 AMPDL BioPharma, Inc. (NASDAQ:PDLI) Analyst Price Targets For The Coming Week - Fiscal Standard
06/18/16 09:09 AM2 Biotech Stocks That Could Raise Their Dividends -- and 1 That Won't - Gilead and Amgen look to be in great shape for increasing dividends. PDL BioPharma? Not so much.
06/16/16 09:58 AMBiotechnology Stocks on our Radar -- Array BioPharma, PDL BioPharma, Advaxis, and TetraLogic Pharma
06/13/16 03:09 PMPDL BioPharma Completes Quarterly Dividend Payment - [at noodls] - INCLINE VILLAGE, Nev., June 13, 2016 /PRNewswire/ -- PDL BioPharma, Inc. (PDL or the Company) (NASDAQ: PDLI) today announced that it has paid the June 13, 2016, quarterly dividend payment of $0.05 per ...
06/11/16 05:55 PMEarnings Overview of the Stocks: FuelCell Energy Inc. (NASDAQ:FCEL), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/11/16 08:37 AMStocks inside Analysts Spotlight: Alkermes plc (NASDAQ:ALKS) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
06/09/16 06:09 PMPDL BioPharma, Inc. (NASDAQ:PDLI) Fundamental Star Rating Report - CML News
06/09/16 08:43 AMTraders Attention Alert: Biocept, Inc. (NASDAQ:BIOC) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Street Updates
06/07/16 05:57 PMTake a look at Price Fluctuations: PDL BioPharma, Inc. (NASDAQ:PDLI) , Nektar Therapeutics (NASDAQ:NKTR) - Street Updates
06/07/16 05:57 PMNotable Earnings Analysis: Unit Corporation (NYSE:UNT), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/06/16 09:26 AMPerformance Review for PDL BioPharma, Inc. (NASDAQ:PDLI) - HNN
06/06/16 09:26 AMNew Broker Ratings For PDL BioPharma, Inc. (NASDAQ:PDLI) - FTSE News
06/03/16 06:18 PMPrice Target Summary Report: Starwood Property Trust, Inc. (NYSE:STWD), PDL BioPharma, Inc. (NASDAQ:PDLI) - Beacon Chronicle
06/03/16 06:18 PMBiotech Movers: Mylan N.V. (NASDAQ:MYL) , PDL BioPharma, Inc. (NASDAQ:PDLI) - Is stories
06/03/16 03:14 PMPDL BIOPHARMA, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders -
06/03/16 08:39 AMPDL BioPharma Inc. (PDLI) is Trading Higher on Unusual Volume for June 01 - Equities.com - PDL BioPharma Inc. (PDLI) is Trading Higher on Unusual Volume for June 01Equities.comPDL BioPharma Inc. (PDLI) experienced unusually high volume on Jun. 01, as the stock gained 0.58% to a closing price of $3.46. The stock saw 2.98 million shares trade hands over the course of the day on 12,874 trades. Given that the stock's average ...PDL BioPharma Inc (PDLI) Raised to Hold at Zacks Investment ResearchLet Me Know About Thisall 2 news articles »
06/02/16 06:09 PMStock's Earnings Analysis Report: PDL BioPharma, Inc. (NASDAQ:PDLI), Weyerhaeuser Co. (NYSE:WY) - Beacon Chronicle - Beacon ChronicleStock's Earnings Analysis Report: PDL BioPharma, Inc. (NASDAQ:PDLI), Weyerhaeuser Co. (NYSE:WY)Beacon ChronicleLast Trade: The Company closed its last session at $31.32 with the loss of -0.57%. The market capitalization of the company is $23.23 Billion, with the average Volume of 5.33 Million. The stock currently has its 52-Week High range of $33.1 and 52-week ...and more »
06/02/16 11:37 AMPDL BIOPHARMA, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits -
06/02/16 08:45 AMPDL BioPharma (NASDAQ:PDLI) & CombiMatrix Corp (NASDAQ:CBMX) Healthcare Stocks in the News - Wall Street 24 - PDL BioPharma (NASDAQ:PDLI) & CombiMatrix Corp (NASDAQ:CBMX) Healthcare Stocks in the NewsWall Street 24On Wednesday, Shares of PDL BioPharma Inc (NASDAQ:PDLI) lost -3.62% to $3.46. The share price is trading in a range of $3.35 – $3.56. The stock exchanged hands with 3.09 Million shares contrast to its average daily volume of 1.41 Million shares.and more »
06/01/16 06:16 PMPDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016 - Nasdaq - PDL BioPharma, Inc. (PDLI) Ex-Dividend Date Scheduled for June 02, 2016NasdaqPDL BioPharma, Inc. ( PDLI ) will begin trading ex-dividend on June 02, 2016. A cash dividend payment of $0.05 per share is scheduled to be paid on June 13, 2016. Shareholders who purchased PDLI prior to the ex-dividend date are eligible for the cash ...PDL BioPharma, Inc. (NASDAQ:PDLI) Analyst ReviewRisers & FallersAre Analysts Bearish PDL BioPharma Inc (NASDAQ:PDLI) After Last Week?HNNTrending Biotech Stocks Update: Celator Pharmaceuticals Inc. (NASDAQ:CPXX) , PDL BioPharma, Inc. (NASDAQ:PDLI)Is storiesPR Newswire (press release) -Finance Dailyall 6 news articles »

Social

About PDL BioPharma

PDL BioPharma logoPDL BioPharma, Inc., formerly Protein Design Labs, Inc., manages a portfolio of patents and royalty assets, consisting of its Queen et al. patents, license agreements with various biotechnology and pharmaceutical companies, and royalty and other assets acquired. The Company provides non-dilutive growth capital and financing solutions to late-stage public and private healthcare companies and offers immediate financial monetization of royalty streams to companies, academic institutions and inventors. It evaluates its investments based on the quality of the income generating assets and potential returns on investment. It is focused on intellectual property asset management, acquiring income generating assets and maximizing value for its stockholders, among others. It receives royalties on sales of over ten humanized antibody products, which include Avastin, Herceptin, Xolair, Kadcyla, Tysabri, Actemra, Gazyva and Entyvio all of which are approved for use.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NASDAQ
  • Symbol: PDLI
  • CUSIP: 69329Y10
Key Metrics:
  • Previous Close: $3.53
  • 50 Day Moving Average: $3.23
  • 200 Day Moving Average: $3.24
  • P/E Ratio: 1.93
  • P/E Growth: 0.46
  • Market Cap: $589.46M
  • Beta: 0.64
  • Current Year EPS Consensus Estimate: $0.54 EPS
  • Next Year EPS Consensus Estimate: $0.05 EPS
Additional Links:
PDL BioPharma (NASDAQ:PDLI) Chart for Wednesday, July, 27, 2016